NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $72.68 +2.18 (+3.09 %) (As of 02/22/2019 04:00 PM ET)Previous Close$72.68Today's Range$70.34 - $72.745052-Week Range$51.88 - $112.25Volume426,028 shsAverage Volume255,818 shsMarket Capitalization$1.76 billionP/E Ratio13.21Dividend YieldN/ABeta0.47 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Magellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona. Receive MGLN News and Ratings via Email Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospitals Sub-IndustryManaged Health Care SectorMedical Current SymbolNASDAQ:MGLN Previous Symbol CUSIP55907920 CIK19411 Webwww.magellanhealth.com Phone602-572-6050Debt Debt-to-Equity Ratio0.55 Current Ratio1.72 Quick Ratio1.67Price-To-Earnings Trailing P/E Ratio13.21 Forward P/E Ratio20.08 P/E Growth2.14 Sales & Book Value Annual Sales$5.84 billion Price / Sales0.30 Cash Flow$10.8966 per share Price / Cash Flow6.67 Book Value$53.09 per share Price / Book1.37Profitability EPS (Most Recent Fiscal Year)$5.50 Net Income$110.20 million Net Margins1.49% Return on Equity10.93% Return on Assets4.67%Miscellaneous Employees10,700 Outstanding Shares24,250,000Market Cap$1.76 billion Next Earnings Date2/28/2019 (Confirmed) OptionableOptionable Magellan Health (NASDAQ:MGLN) Frequently Asked Questions What is Magellan Health's stock symbol? Magellan Health trades on the NASDAQ under the ticker symbol "MGLN." How were Magellan Health's earnings last quarter? Magellan Health Inc (NASDAQ:MGLN) released its earnings results on Thursday, April, 26th. The company reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.01 by $0.20. The firm earned $1.81 billion during the quarter, compared to analysts' expectations of $1.83 billion. Magellan Health had a return on equity of 10.93% and a net margin of 1.49%. The business's revenue was up 38.3% on a year-over-year basis. During the same period last year, the business earned $1.09 earnings per share. View Magellan Health's Earnings History. When is Magellan Health's next earnings date? Magellan Health is scheduled to release their next quarterly earnings announcement on Thursday, February 28th 2019. View Earnings Estimates for Magellan Health. What guidance has Magellan Health issued on next quarter's earnings? Magellan Health updated its FY19 earnings guidance on Friday, December, 7th. The company provided EPS guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.50. The company issued revenue guidance of $7.2-7.5 billion, compared to the consensus revenue estimate of $7.11 billion.Magellan Health also updated its FY 2019 guidance to $3.70-4.69 EPS. What price target have analysts set for MGLN? 4 analysts have issued 1 year target prices for Magellan Health's stock. Their forecasts range from $68.00 to $84.00. On average, they expect Magellan Health's stock price to reach $73.50 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price. View Analyst Price Targets for Magellan Health. What is the consensus analysts' recommendation for Magellan Health? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health. Has Magellan Health been receiving favorable news coverage? News coverage about MGLN stock has trended neutral this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Magellan Health earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. Who are some of Magellan Health's key competitors? Some companies that are related to Magellan Health include Encompass Health (EHC), Healthscope (HSO), MEDNAX (MD), Select Medical (SEM), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), SunLink Health Systems (SSY), Animalcare Group (ANCR), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). What other stocks do shareholders of Magellan Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), Cornerstone Total Return Fund (CRF), Ford Motor (F), Netflix (NFLX), SandRidge Permian Trust (PER), SunCoke Energy Partners (SXCP), Cornerstone Strategic Value Fund (CLM), CBL & Associates Properties (CBL), Navios Maritime Midstream Partners (NAP) and Nektar Therapeutics (NKTR). Who are Magellan Health's key executives? Magellan Health's management team includes the folowing people: Mr. Barry Morgan Smith, Chairman . CEO & CEO of Magellan Healthcare (Age 65)Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 63)Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)Ms. Renie Shapiro Silver, SVP - Corp. Fin. Who are Magellan Health's major shareholders? Magellan Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.71%), Dimensional Fund Advisors LP (8.45%), Victory Capital Management Inc. (3.14%), Northern Trust Corp (3.00%), Prudential PLC (1.82%) and D. E. Shaw & Co. Inc. (1.53%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health. Which institutional investors are selling Magellan Health stock? MGLN stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Millennium Management LLC, QS Investors LLC, SG Americas Securities LLC, Citigroup Inc., Geode Capital Management LLC, KBC Group NV and LSV Asset Management. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Daniel N Gregoire and Mostafa Kamal. View Insider Buying and Selling for Magellan Health. Which institutional investors are buying Magellan Health stock? MGLN stock was acquired by a variety of institutional investors in the last quarter, including Engaged Capital LLC, Victory Capital Management Inc., Two Sigma Advisers LP, Two Sigma Investments LP, Prudential PLC, D. E. Shaw & Co. Inc., Bank of America Corp DE and Dean Investment Associates LLC. View Insider Buying and Selling for Magellan Health. How do I buy shares of Magellan Health? Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Magellan Health's stock price today? One share of MGLN stock can currently be purchased for approximately $72.68. How big of a company is Magellan Health? Magellan Health has a market capitalization of $1.76 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe. What is Magellan Health's official website? The official website for Magellan Health is http://www.magellanhealth.com. How can I contact Magellan Health? Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected] MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 285 (Vote Outperform)Underperform Votes: 290 (Vote Underperform)Total Votes: 575MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?